Heparin Versus Oral Anticoagulant Therapy in Coronary Atherosclerosis

Utilizing a modified capillary tube technique, analysis revealed a significantly higher mean blood coagulation time in a group of 14 dogs with mastocytoma when compared to the mean coagulation time of 70 non-mastocytoma dogs. In dogs with mastocytoma, approximately one third had intermediate size tumors and a prolonged mean coagulation time and two thirds had a mean coagulation time that did not differ significantly from the mean of the non-mastocytoma dogs. Evidence for heparin release and possible heparin inactivating mechanisms is reviewed.

show abstract

Canine Mastocytoma

Hottendorf

Nielsen

Kenyon

1965

Pathologia veterinaria

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Heparin Versus Oral Anticoagulant Therapy in Coronary Atherosclerosis

Cited by 1 publication

References 0 publications

Canine Mastocytoma

Canine Mastocytoma

Contact Info

Product

Resources

About